Literature DB >> 17446502

Topical azithromycin: new evidence?

Hannah Kuper, Richard Wormald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17446502      PMCID： PMC1954780          DOI： 10.1136/bjo.2006.107102

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  10 in total

1.  Elimination of trachoma: are we in danger of being blinded by the randomised controlled trial?

Authors:  H R Wright; J E Keeffe; H R Taylor
Journal:  Br J Ophthalmol       Date:  2006-11       Impact factor: 4.638

2.  Trachoma, antibiotics and randomised controlled trials.

Authors:  B Shapiro; K Dickersin; T Lietman
Journal:  Br J Ophthalmol       Date:  2006-12       Impact factor: 4.638

3.  Reduction of trachoma in a sub-Saharan village in absence of a disease control programme.

Authors:  P J Dolin; H Faal; G J Johnson; D Minassian; S Sowa; S Day; J Ajewole; A A Mohamed; A Foster
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

Review 4.  Antibiotics for trachoma.

Authors:  D Mabey; N Fraser-Hurt; C Powell
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

5.  Mass treatment with single-dose azithromycin for trachoma.

Authors:  Anthony W Solomon; Martin J Holland; Neal D E Alexander; Patrick A Massae; Aura Aguirre; Angels Natividad-Sancho; Sandra Molina; Salesia Safari; John F Shao; Paul Courtright; Rosanna W Peeling; Sheila K West; Robin L Bailey; Allen Foster; David C W Mabey
Journal:  N Engl J Med       Date:  2004-11-04       Impact factor: 91.245

6.  Efficacy and safety of short duration azithromycin eye drops versus azithromycin single oral dose for the treatment of trachoma in children: a randomised, controlled, double-masked clinical trial.

Authors:  Isabelle Cochereau; Pablo Goldschmidt; André Goepogui; Tayyab Afghani; Laurent Delval; Pascale Pouliquen; Tristan Bourcier; Pierre-Yves Robert
Journal:  Br J Ophthalmol       Date:  2006-09-27       Impact factor: 4.638

7.  Azithromycin in control of trachoma.

Authors:  J Schachter; S K West; D Mabey; C R Dawson; L Bobo; R Bailey; S Vitale; T C Quinn; A Sheta; S Sallam; H Mkocha; D Mabey; H Faal
Journal:  Lancet       Date:  1999-08-21       Impact factor: 79.321

8.  Global data on visual impairment in the year 2002.

Authors:  Serge Resnikoff; Donatella Pascolini; Daniel Etya'ale; Ivo Kocur; Ramachandra Pararajasegaram; Gopal P Pokharel; Silvio P Mariotti
Journal:  Bull World Health Organ       Date:  2004-12-14       Impact factor: 9.408

9.  Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments.

Authors:  Muluken Melese; Jaya Devi Chidambaram; Wondu Alemayehu; David Chung Lee; Elizabeth H Yi; Vicky Cevallos; Zhaoxia Zhou; Cathy Donnellan; Michael Saidel; John P Whitcher; Bruce D Gaynor; Thomas M Lietman
Journal:  JAMA       Date:  2004-08-11       Impact factor: 56.272

10.  Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study.

Authors:  Sheila K West; Beatriz Munoz; Harran Mkocha; Martin J Holland; Aura Aguirre; Anthony W Solomon; Allen Foster; Robin L Bailey; David C W Mabey
Journal:  Lancet       Date:  2005-10-08       Impact factor: 79.321
  10 in total
  3 in total

1.  Elimination of blinding trachoma in oman.

Authors:  Rajiv Khandekar
Journal:  Oman Med J       Date:  2009-04

Review 2.  Strategies to control trachoma.

Authors:  Anu A Mathew; Angus Turner; Hugh R Taylor
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

Review 3.  Azithromycin: The First Broad-spectrum Therapeutic.

Authors:  Anton Firth; Praveen Prathapan
Journal:  Eur J Med Chem       Date:  2020-08-19       Impact factor: 6.514
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.